Published in Women's Health Weekly, April 8th, 2010
The study, which is the basis for seeking FDA approval, also indicated that nearly 40 percent of women without disease could have avoided potentially painful and invasive follow up exams, including biopsy.
"We believe that these results show that our LightTouch technology can be a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.